{
    "fields": {
        "treatment_regimens": {
            "type": "array",
            "description": "A list of all treatment regimens mentioned in the study. Include every treatment or combination (e.g., monotherapy, combination therapy) exactly as referenced in the document."
        },
        "countries": {
            "type": "array",
            "description": "A list of all countries where the study was conducted. This should capture every geographical location related to patient enrollment or research sites mentioned in the document."
        },
        "populations": {
            "type": "array",
            "description": "A list of population groups with their specific clinical characteristics. Each entry should comprehensively capture details for a subgroup of patients.",
            "items": {
                "type": "object",
                "properties": {
                    "stage_histology": {
                        "type": "string",
                        "description": "Combined disease stage and histology information, including details like the progression stage (e.g., Stage III/IV) and histological classification (e.g., NSCLC, NSCC) as provided in the document."
                    },
                    "pdl1_status": {
                        "type": "string",
                        "description": "The PD-L1 expression status, reported either as a percentage or threshold (e.g., 'â‰¥50%'). Capture the value exactly as presented in the study."
                    },
                    "n": {
                        "type": "number",
                        "description": "The size of the population group (number of patients or subjects). Ensure the numeric value is extracted accurately."
                    }
                },
                "required": [
                    "stage, histology",
                    "pdl1_status",
                    "n"
                ]
            }
        },
        "results": {
            "type": "object",
            "description": "An object capturing the treatment outcomes and statistical comparisons from the study. This should include both general and treatment-specific outcome measures.",
            "properties": {
                "median_os": {
                    "type": "string",
                    "description": "The median overall survival, usually expressed in months (e.g., '15.2 months' or 'not reached'). Ensure to capture the value exactly as reported."
                },
                "median_rw_pfs": {
                    "type": "string",
                    "description": "The median real-world progression-free survival if available. This reflects the duration where patients did not experience progression under real-world conditions."
                },
                "median_pfs": {
                    "type": "string",
                    "description": "The median progression-free survival, used if real-world data is not provided. Capture the value (numeric or text such as 'not reached') as it appears in the document."
                },
                "os_12_month": {
                    "type": "string",
                    "description": "The 12-month overall survival rate, typically presented as a percentage. Include any associated symbols or qualifiers exactly as mentioned."
                },
                "treatment_specific_results": {
                    "type": "object",
                    "description": "An object containing results specific to each treatment regimen. Each key should correspond to a treatment regimen, with its value being another object that captures the detailed outcomes for that regimen."
                },
                "group_difference": {
                    "type": "string",
                    "description": "Any statistical comparisons (e.g., p-values) that indicate differences between treatment groups. Capture the information exactly as provided in the study."
                }
            }
        }
    }
}